Search
+
    SEARCHED FOR:

    TYPE 1 DIABETES

    Do you eat rice before vegetables? Research suggests switching the order could make a difference

    Eating the same lunch in a different order may change how quickly your blood sugar rises after a meal. Research suggests that eating vegetables before carbohydrate-rich foods such as rice can reduce short-term post-meal glucose increases.

    MIT scientists implanted oxygen-producing devices with insulin-making cells in mice and rats; the cells remained active for at least 90 days and helped control blood sugar

    A groundbreaking study reveals a new wireless device aimed at improving diabetes treatment by fostering the functionality of insulin-producing cells. This innovative technology enables these cells to effectively produce insulin for as long as 90 days in rodents. Enhancements in waterproofing and electronics have boosted the device's performance, with researchers striving to extend its operational life to two years, paving the way for advanced cellular therapies in diabetes management.

    These large-, mid- and small-cap stocks have upside potential of more than 20% in 1 year, according to analysts

    The probability of a sharp, damaging downturn now appears low, and the broad direction favours the market. So, the stance should be the same as in these past few weeks: Shedding fear, but cautiously optimistic. Focus on the business under the stock you are interested in, and keep one eye on what is happening globally.

    World Diabetes Day 2026: Not just blood sugar, why eye checkups should also be a priority

    For individuals managing diabetes, being vigilant about eye health is vital due to the risk of diabetic retinopathy and other eye complications. It is recommended that comprehensive eye exams begin shortly after diagnosis, as early detection is key. Regular screenings, alongside effective blood sugar management, can greatly diminish the chance of serious vision impairment, underscoring the necessity of prioritizing eye care in diabetes treatment plans.

    Lupin partner Sandoz launches RanluspecTM across Europe for retinal disease treatment

    Lupin Ltd has partnered with Sandoz to launch RanluspecTM, a biosimilar for Ranibizumab, across Europe. This launch will help to improve access to treatments for retinal and choroidal vascular diseases. The European Commission previously approved RanluspecTM in vial and syringe-filled presentations for medical use. The biosimilar targets conditions such as wet age-related macular degeneration and diabetic macular edema.

    US FDA adds rare vision-loss warning to popular GLP-1 drugs

    The US FDA will add a warning about a rare eye condition that can cause permanent vision loss to the labels of all GLP-1 drugs, including Ozempic, Wegovy, Mounjaro and Zepbound. The condition was found in around 6 per 100,000 patients taking the drugs for at least a year.

    • Could falling asleep earlier help with weight loss? Here’s what researchers found

      A study of adults with prediabetes found a link between falling asleep earlier and losing more weight. Most participants still fell asleep after midnight by the end of the eight-week program. The results raise a question researchers haven’t answered yet: Would changing bedtime on its own make a difference?

      Dr Reddy's Laboratories receives ANVISA approval for generic semaglutide injection in Brazil

      Dr Reddy’s Laboratories obtained marketing authorisation from Brazil’s ANVISA for a generic semaglutide injection. The product will be available as a pre-filled, multi-dose pen in two dosages for weekly administration. This drug targets treatment for type 2 diabetes alongside diet and exercise, particularly in patient groups needing alternative therapies. Brazil's diabetes prevalence creates significant market demand, estimated at approximately $244.6 million.

      Your old medical reports may reveal a disease risk you don't know about. Here's how AI can help

      AI could help uncover hidden health risks by analysing years of old medical reports, blood tests, prescriptions and hospital records. Predictive AI models may identify patterns linked to conditions such as cardiac arrhythmias, liver disease and Type 1 diabetes, potentially allowing earlier medical intervention. However, incomplete medical records, data inconsistencies and false alerts remain major challenges.

      Drug-free treatment for diabetes and obesity may become possible as scientists develop a wireless device that detects high blood sugar levels and removes excess sugar from bloodstream

      Diabetes treatment news: A team of scientists from France and Switzerland developed a wireless electronic device to manage diabetes. This device removes excess glucose from the bloodstream, potentially providing a drug-free treatment option. In studies, the device effectively regulated glucose levels in diabetic mice while promoting fat usage for energy. Researchers connected it to a continuous glucose monitor, ensuring automatic activation. Further human trials are necessary to ensure safety and effectiveness in patients.

      Short-term headwinds, yes; owning the ecosystem is better: 20 healthcare stocks with downside risk of 23% to upside potential of 41%

      The healthcare sector is under scrutiny. The issue is pricing: What medicines cost and on what hospitals and the rest of the health ecosystem charge. And both the government and the courts have stepped in. At one level, that is not entirely a bad thing. Check out Stock Reports Plus, powered by Refinitiv, for price targets of over 4,000 listed stocks along with detailed company analysis focusing on five key components – earnings, fundamentals, relative valuation, risk, and price momentum – to generate standardised scores. SR+ Reports is a complimentary offering to ETPrime members.

      Alexander Zverev has achieved the top position in the world tennis rankings after overcoming various challenges. He capitalized on injuries to rivals like Carlos Alcaraz and Jannik Sinner this season. Zverev claimed titles at the French Open and US Open, marking a significant turnaround in his career. His previous struggles include an ankle injury and past allegations, which he has consistently denied.

      These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analysts

      When a market is as jittery as it is right now, poor numbers are treated harshly. A new-age company in the business of buying and selling used cars reported numbers that fell short, and the street punished the stock severely. But it is not just the clear misses. Anything that is well-owned and presents disappointing numbers is seeing double-digit cuts.

      Why does the prostate enlarge with age? Scientists discover unusual cells hiding in one key region

      Researchers at Johns Hopkins University have uncovered a significant presence of WIF1-positive basal cells in the prostate, particularly within the transition zone linked to benign prostatic hyperplasia. Their findings suggest these cells may play a role in prostate growth processes, though the limited sample size of the study calls for more extensive research to confirm their impact.

      As weight-loss drug users turn to dietary supplements, doctors, regulators raise flags

      The growing use of GLP-1 weight-loss drugs such as Ozempic and Wegovy is driving demand for dietary supplements in the US, as users seek to manage side effects including nausea, fatigue and constipation. Supplement sales exceeded $74 billion in 2025, while TikTok Shop generated more than $1 billion in supplement sales.

      Have you been told you have prediabetes? A 12-week study found a surprising blood sugar benefit from lifting weights twice a week

      A 12-week strength-training programme helped 34% of participants with prediabetes return to normal blood glucose levels, according to a clinical trial published in PLOS ONE in 2017. The participants trained twice a week under supervision. The finding offers a useful lesson for people concerned about type 2 diabetes.

      GLP-1 and fertility: Could weight-loss medicines help women conceive? Here's what new reports reveal

      insulin resistance can disrupt reproductive hormones. For women with polycystic ovary syndrome (PCOS), ovulation may become irregular. Getting pregnant can then be harder. Losing weight and improving insulin sensitivity may help some women ovulate more regularly.

      WHO says medicines, surgery not first-line treatment for childhood obesity

      The World Health Organization has released guidelines on treating obesity among children and adolescents. It emphasizes structured diets, physical activity, and behavioral changes as primary treatment methods. Weight-loss medications are not recommended for children aged zero to nine years. For adolescents, these medications may only be considered after conventional methods fail to deliver results. Mental health support is also crucial as obesity often leads to stigma and emotional issues.

      The Nobel Prize week is kicking off in Stockholm with the medicine award for understanding immune system response

      This year's Nobel Prizes will commence on Monday with the medicine prize awarded at the Karolinska Institute. Last year, three scientists won the medicine prize for their work on the immune system. Their research has been crucial for understanding autoimmune diseases like Type 1 diabetes and lupus. Following the medicine prize, additional prizes for physics, chemistry, and literature will be announced.

      Load More
    The Economic Times
    BACK TO TOP
    Advertisement